Early Phase 1 Alzheimer's Disease Trial, Recruiting (NCT06932809)

Early Phase 1 Alzheimer's Disease Trial, Recruiting NCT06932809 Sponsor: University of Pennsylvania Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06932809 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man or woman between 40 and 85 years old
You are willing to sign a consent form agreeing to take part, OR if you are unable to sign for yourself, a trusted person (such as a family member) can be present to help with consent and accompany you to visits
Note: You may be asked if you would be willing to donate your brain for research after death, but saying no will not stop you from joining the trial

Who may not be able to join:

Women who are currently pregnant or breastfeeding
People who have a type of movement disorder (parkinsonism) that does not match the specific types this study is looking at (confirm with trial site)
People with a significant history of alcohol or drug misuse or dependency, either noted in medical records or self-reported
People who are unable to have brain scans (imaging), have a small tube placed in a vein or artery, or have blood drawn, for any reason
People who have a medical implant or device that is not safe to use near an MRI scanner (such as certain pacemakers or metal implants)
People who have any current health condition, illness, or disorder that a doctor feels could put them at risk or prevent them from fully taking part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06932809

Sponsor: University of Pennsylvania

Phase: Early Phase 1

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT06932809

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man or woman between 40 and 85 years old
You are willing to sign a consent form agreeing to take part, OR if you are unable to sign for yourself, a trusted person (such as a family member) can be present to help with consent and accompany you to visits
Note: You may be asked if you would be willing to donate your brain for research after death, but saying no will not stop you from joining the trial

Who may not be able to join:

Women who are currently pregnant or breastfeeding
People who have a type of movement disorder (parkinsonism) that does not match the specific types this study is looking at (confirm with trial site)
People with a significant history of alcohol or drug misuse or dependency, either noted in medical records or self-reported
People who are unable to have brain scans (imaging), have a small tube placed in a vein or artery, or have blood drawn, for any reason
People who have a medical implant or device that is not safe to use near an MRI scanner (such as certain pacemakers or metal implants)
People who have any current health condition, illness, or disorder that a doctor feels could put them at risk or prevent them from fully taking part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

University of Pennsylvania

Registry

ClinicalTrials.gov

Start date

9 May 2025

Est. completion

1 April 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Organ Biodistribution or Dosimetry; PET Uptake of Tracer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov